These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23249695)

  • 41. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fibrin lysability is associated with central obesity and inflammation in women with polycystic ovary syndrome.
    Godtfredsen ACM; Sidelmann JJ; Gram JB; Andersen M; Glintborg D
    Acta Obstet Gynecol Scand; 2020 Aug; 99(8):1078-1084. PubMed ID: 32048272
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
    Robinson S; Henderson AD; Gelding SV; Kiddy D; Niththyananthan R; Bush A; Richmond W; Johnston DG; Franks S
    Clin Endocrinol (Oxf); 1996 Mar; 44(3):277-84. PubMed ID: 8729522
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS.
    Shorakae S; Ranasinha S; Abell S; Lambert G; Lambert E; de Courten B; Teede H
    Clin Endocrinol (Oxf); 2018 Nov; 89(5):628-633. PubMed ID: 29992612
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Salicylate administration suppresses the inflammatory response to nutrients and improves ovarian function in polycystic ovary syndrome.
    González F; Mather KJ; Considine RV; Abdelhadi OA; Acton AJ
    Am J Physiol Endocrinol Metab; 2020 Oct; 319(4):E744-E752. PubMed ID: 32830548
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between inflammatory biomarker serum procalcitonin and obesity in women with polycystic ovary syndrome.
    Rashad NM; El-Shal AS; Abdelaziz AM
    J Reprod Immunol; 2013 Apr; 97(2):232-9. PubMed ID: 23218400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome.
    Nehir Aytan A; Bastu E; Demiral I; Bulut H; Dogan M; Buyru F
    Gynecol Endocrinol; 2016 Sep; 32(9):709-713. PubMed ID: 26951881
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study.
    Rashid A; Masood A; Wani IA; Hafeez I; Parvez T; Zagar MA; Ganie MA
    Fertil Steril; 2020 Jun; 113(6):1299-1307.e2. PubMed ID: 32482259
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyperandrogenism induces a proinflammatory TNFα response to glucose ingestion in a receptor-dependent fashion.
    González F; Sia CL; Bearson DM; Blair HE
    J Clin Endocrinol Metab; 2014 May; 99(5):E848-54. PubMed ID: 24512496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
    Li L; Chen X; He Z; Zhao X; Huang L; Yang D
    J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
    Karadağ C; Yoldemir T
    J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Endothelial dysfunction in young women with polycystic ovary syndrome: relationship with insulin resistance and low-grade chronic inflammation.
    Tarkun I; Arslan BC; Cantürk Z; Türemen E; Sahin T; Duman C
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5592-6. PubMed ID: 15531516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Full-length visfatin levels are associated with inflammation in women with polycystic ovary syndrome.
    Lajunen TK; Purhonen AK; Haapea M; Ruokonen A; Puukka K; Hartikainen AL; Savolainen MJ; Morin-Papunen L; Tapanainen JS; Franks S; Järvelin MR; Herzig KH
    Eur J Clin Invest; 2012 Mar; 42(3):321-8. PubMed ID: 21913913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome.
    Koiou E; Tziomalos K; Dinas K; Katsikis I; Kandaraki EA; Tsourdi E; Mavridis S; Panidis D
    Endocr J; 2012; 59(1):21-9. PubMed ID: 21996594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Insulin resistance and cardiovascular risk factors in women with PCOS who have normal glucose tolerance test.
    Yildir IC; Kutluturk F; Tasliyurt T; Yelken BM; Acu B; Beyhan M; Erkorkmaz U; Yilmaz A
    Gynecol Endocrinol; 2013 Feb; 29(2):148-51. PubMed ID: 23127112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Obesity, hormonal and metabolic abnormalities in adolescent girls with polycystic ovary syndrome].
    Ságodi L; Lombay B; Vámosi I; Barkai L
    Orv Hetil; 2013 Aug; 154(31):1226-34. PubMed ID: 23895991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.